Distant lymph nodes compensate for resected tumor-draining lymph nodes during cancer immunotherapy.

Distant lymph nodes can compensate for resected tumor-draining lymph nodes to sustain cancer immunotherapy responses, with 100% of melanoma patients remaining responsive after LN removal.

• Why it matters: Understanding how anti-cancer immunity persists after lymph node removal addresses a critical gap in optimizing surgical and immunotherapy strategies, especially since lymph nodes are key sites for immune activation.
• What they did: The study examined immune responses in melanoma patients and mouse models, showing that soluble tumor antigens are rerouted to distant lymph nodes, where they activate T cells via dendritic cells, supporting systemic immunity.
• The result: This rerouting enables distant lymph nodes to maintain anti-tumor responses after primary lymph node removal, and targeted delivery of immune checkpoint blockade to these sites further enhances therapeutic efficacy.